Atom Investors LP Eli Lilly & CO Transaction History

Atom Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $435,646 - $546,333	601 Added 134.75%	1,047 $947,000
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $264,121 - $353,356	446 New	446 $346,000
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $207,638 - $277,636	592 New	592 $277,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $333,447 - $388,532	1,037 New	1,037 $379,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $483,223 - $639,421	-3,704 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $541,598 - $626,457	3,704 New	3,704 $548,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.